A5022208995- Mobile Health and mHealth Applications
- Cardiovascular Health and Risk Factors
- Diabetes Treatment and Management
- Cardiovascular Function and Risk Factors
- Machine Learning in Healthcare
- Pharmacological Effects and Toxicity Studies
- Epilepsy research and treatment
- Diabetes Management and Education
- Diabetes Management and Research
- Chronic Disease Management Strategies
Sanofi (United States)
2022-2023
UCB Pharma (United States)
2018
Background: Dario Diabetes Solution (DDS) is a digital health application (app) that combines blood glucose (BG) monitoring system with smartphone app, allowing tracking of BG levels in real time. This study evaluated effectiveness DDS on HbA1c between users and matched nonusers. Methods: retrospective cohort included adults type 2 diabetes mellitus (T2DM) baseline (BL) ≥7% who used (users) or received usual care (nonusers) January 1, 2017, to October 31, 2021. BL period was 1 year before...
Background: Dario Diabetes Solution (DDS) is a digital health application (app) for type 2 diabetes mellitus (T2DM) management that combines blood glucose (BG) meter and mobile app, allowing patients (pts) to track BG levels in real time. This study compared all-cause healthcare resource utilization (HCRU; inpatient + ER) charges DDS users vs matched nonusers. Methods: retrospective cohort (pt selection window: 1JAN2017 - 31APR2021) included adults (≥18 years) with T2DM receiving...
Background: Dario Diabetes Solution (DDS) is a digital health application (app) that combines blood glucose (BG) monitoring system with smartphone app, allowing tracking of BG levels in real time. This study assessed effects DDS on HbA1c adults type 2 diabetes mellitus (T2DM) baseline (BL) ≥8% and severe hypoglycemia (SH). Methods: retrospective cohort analysis included T2DM who used (users) nonusers from 1JAN2017 to 31OCT2021. BL period was 1 year before index date (users, first...